UK Diabetes Devices Market Report 2022 to 2030

UK Diabetes Devices Market Analysis

$ 3999

The UK Diabetes Devices Market is expected to witness growth from $591 Mn in 2022 to $887 Mn in 2030 with a CAGR of 5.20% for the forecasted year 2022-30. Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market is segmented by type and by the end user. Some key players in this market include Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom.

ID: IN10GBMD007 CATEGORY: Medical Devices GEOGRAPHY: UK AUTHOR: Jigyasu Bhandari

Buy Now

UK Diabetes Devices Healthcare Market Executive Analysis

The UK Diabetes Devices Market size is at around $591 Mn in 2022 and is projected to reach $887 Mn in 2030, exhibiting a CAGR of 5.20% during the forecast period. The UK spend $343.38 billion on healthcare overall in 2021, a nominal rise of 7.4% over the amount spent in 2020. Real growth in total current healthcare spending in the UK increased by 7.1% in 2021 compared to 10.0% in 2020 after accounting for the effects of inflation on the general economy. In the UK, healthcare expenditures accounted for about 11.9% of GDP in 2021, which is comparable to the percentage in 2020.

The total number of diabetics in the UK as of 2021 proved 3.9 million, or about 6% of the population. Around 90% of these have type 2 diabetes, while only 10% have type 1. In addition, there are approximately 1 million untreated types 2 diabetics in the UK. Diabetes is becoming more common in the UK as well. In the UK, approximately 200,000 new cases of diabetes were diagnosed in 2019, translating to about 550 new cases per day. Type 2 diabetes accounted for about 90% of these new cases, while type 1 diabetes accounted for about 10%. Insulin is administered by means of a catheter inserted under the skin using a small instrument called an insulin pump. People with diabetes who use insulin pumps can keep better blood glucose control because they can deliver more precise insulin dosing than people who use insulin injections. With the aid of insulin pumps, diabetes management is more flexible and less constrained as people with diabetes can modify their insulin dosing to suit their particular requirements.

UK Diabetes Devices Market Analysis

Market Dynamics

Market Growth Drivers

Diabetes is becoming more common in the UK, which is raising the demand for diabetes devices. Continuous glucose monitoring systems and flash glucose monitoring systems are two examples of non-invasive and slightly invasive diabetes devices that are in increasing demand in the UK. The market for diabetes devices is growing in the UK because these devices are more convenient and cause less disruption to everyday life than conventional blood glucose monitoring techniques, like finger pricks. The UK market for diabetes devices is continuously changing as new technologies and innovations are created. The market for UK Diabetes devices is expanding as a result of major developments in CGM systems, insulin pumps, and artificial pancreas systems, for instance.

Market Restraints

Demand for more recent diabetes devices in the UK may be constrained by some patients’ preference for more conventional diabetes treatment techniques in the UK, such as insulin injections and blood glucose metres. In the UK, diabetes equipment can be pricey, and some patients might not be able to purchase it. This may impede some patients' access to the devices they require to control their diabetes and restrict the market growth of diabetes devices in the UK.

Competitive Landscape

Key Players

Magstim (UK)
Deltex Medical (UK)
Johnson & Johnson
DarioHealth
Medtronic
Philipps Healthcare
Dexcom

Recent Notable Deals

2021: Dexcom and NHS England launched a partnership in 2021 to offer the G5 continuous glucose monitoring system to qualified type 1 diabetes patients. The partnership enhances patient diabetes control while increasing access to Dexcom's CGM technology in the UK.

Healthcare Policies and Regulatory Landscape

In the UK, the National Health Service (NHS) offers advice for the use of diabetes devices as part of its guidelines for the management of diabetes. These recommendations may have an impact on how individuals and healthcare professionals use diabetes devices. In the European Union (EU), including the UK, the sale and use of medical devices are governed by the Medical Devices Regulation (MDR), a collection of rules. Before their goods can be sold in the EU, medical device manufacturers must comply with the MDR, which includes proving the devices' safety and efficacy. In the UK, recommendations for the use of diabetes devices are provided by the National Institute for Health and Care Excellence (NICE). NICE recommendations may have an impact on how individuals and healthcare professionals use diabetes devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Diabetes Devices Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents

Blood glucose monitoring systems
Self-monitoring blood glucose monitoring systems
Continuous glucose monitoring systems
Test strips/Test papers
Lancets/Lancing Devices
Insulin delivery Devices
Insulin pumps
Insulin pens
Insulin syringes and needles
Diabetes management mobile applications

By End User (Revenue, USD Billion):

The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.

Hospitals & Specialty Clinics
Self & Home Care

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

The market is segmented by type and by the end user.

The UK Diabetes Devices Market is studied from 2022-2030.

Magstim, Deltex Medical, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V., Roche and Dexcom are the major companies operating in the UK diabetes devices market.